PRCT

PROCEPT BioRobotics (PRCT)

About PROCEPT BioRobotics (PRCT)

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Details

Daily high
$36.20
Daily low
$34.58
Price at open
$36.17
52 Week High
$90.47
52 Week Low
$27.80
Market cap
2.0B
Dividend yield
0.00%
Volume
996,130
Avg. volume
1.6M
P/E ratio
-23.47

PROCEPT BioRobotics News

Details

Daily high
$36.20
Daily low
$34.58
Price at open
$36.17
52 Week High
$90.47
52 Week Low
$27.80
Market cap
2.0B
Dividend yield
0.00%
Volume
996,130
Avg. volume
1.6M
P/E ratio
-23.47